Apotheco Pharmacy Group Appoints Natasha Hennessy as CEO, Succeeding David Vucurevich

New York & Chicago - Apotheco Pharmacy Group, a leading network of specialized pharmacies serving the dermatology market, announces the promotion of Natasha Hennessy, PharmD. to Chief Executive Officer. Ms. Hennessy will assume her new role on January 1, 2024, following the retirement of David Vucurevich, who will transition to Executive Chairman of the Board.

With over 15 years of experience in the pharmacy industry, Ms. Hennessy brings extensive knowledge and a proven track record of driving growth to her new position. She joined Apotheco in July 2023 as Executive President and has since demonstrated outstanding executive leadership and a commitment to delivering exceptional results.

Mr. Vucurevich praised Ms. Hennessy, stating that her appointment has facilitated a seamless transition. He commended her executive leadership abilities and congratulated her on the promotion. Ms. Hennessy expressed gratitude for Mr. Vucurevich's contribution to the company's success and expressed excitement about leading Apotheco in its next phase of growth.

Prior to joining Apotheco, Ms. Hennessy served as Chief Operating Officer of Genoa Healthcare, the largest provider of pharmacy and medication management services in the behavioral health market. Her expertise in executing technology-enabled growth initiatives and operating large, multi-site pharmacy networks will be valuable in further positioning Apotheco as a leading pharmacy network serving specialized areas of healthcare.

Apotheco gained significant support for its growth when Waud Capital Partners (WCP), a private equity firm specializing in the pharmacy market, completed a majority investment in 2019. Since then, Apotheco has expanded its network of pharmacy locations, establishing itself as a digitally-enabled, one-stop shop for dermatology prescriptions.

Chris Graber, Partner at Waud Capital Partners and a member of the Board of Apotheco, expressed enthusiasm about Ms. Hennessy's promotion, highlighting her instrumental role in the company's success. He emphasized her ability to deliver enhanced value for customers and execute growth initiatives.

About Apotheco Pharmacy Group

Apotheco is a clinically-focused network of specialized pharmacies catering to various specialties and therapeutic areas, with a focus on dermatology. The company's high-touch model benefits prescribers, patients, and payors by providing convenience, cost savings, and exceptional customer service. For more information, visit www.apothecopharmacy.com.

About Waud Capital Partners

Headquartered in Chicago, Waud Capital Partners is a growth-oriented private equity firm with a strong focus in the healthcare and software & technology industries. With approximately $4.6 billion of assets under management, Waud Capital seeks to partner with experienced management teams to build market-leading companies. Since its founding in 1993, Waud Capital has completed over 450 investments, including platform companies and follow-on opportunities. For more information, visit www.waudcapital.com.

In conclusion, Apotheco Pharmacy Group has promoted Natasha Hennessy to the position of Chief Executive Officer, effective January 1, 2024. Ms. Hennessy's extensive experience and proven track record in the pharmacy industry make her ideally suited for this role. Apotheco continues to solidify its position as a leading network of specialized pharmacies, thanks to the support of Waud Capital Partners. With Ms. Hennessy at the helm, the company looks forward to further growth and success in serving the dermatology market and other specialized areas of healthcare.